Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A look at autoimmunity and inflammation in the eye
Rachel R. Caspi
Rachel R. Caspi
Published September 1, 2010
Citation Information: J Clin Invest. 2010;120(9):3073-3083. https://doi.org/10.1172/JCI42440.
View: Text | PDF
Review Article has an altmetric score of 14

A look at autoimmunity and inflammation in the eye

  • Text
  • PDF
Abstract

Autoimmune and inflammatory uveitis are a group of potentially blinding intraocular inflammatory diseases that arise without a known infectious trigger and are often associated with immunological responses to unique retinal proteins. In the United States, about 10% of the cases of severe visual handicap are attributed to this group of disorders. As I discuss here, experimental models of ocular autoimmunity targeting retinal proteins have brought about a better understanding of the basic immunological mechanisms involved in the pathogenesis of uveitis and are serving as templates for the development of novel therapies.

Authors

Rachel R. Caspi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 12 17 13 26 28 16 18 14 12 17 21 13 12 13 12 1 1 246
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2017 (12)

Title and authors Publication Year
Commensal microbiota as a potential trigger of autoimmune uveitis
R Horai, HN Sen, RR Caspi
Expert Review of Clinical Immunology 2017
Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells
JR Wei, X Wen, PW Bible, Z Li, RB Nussenblatt, L Wei
Journal of Ocular Pharmacology and Therapeutics 2017
The effect of anakinra on retinal function in isolated perfused vertebrate retina
M Ranjbar, T Schneider, C Brand, S Grisanti, J Lüke, M Lüke
Journal of Current Ophthalmology 2017
The promise of stem cell-based therapeutics in ophthalmology
I Aharony, S Michowiz, N Goldenberg-Cohen
NEURAL REGEN RES 2017
MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis
DA Lipski, R Dewispelaere, V Foucart, LE Caspers, M Defrance, C Bruyns, F Willermain
Journal of Neuroinflammation 2017
Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases
S Ding, S Kumar, P Mok
International journal of molecular sciences 2017
Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism: Dectin-2/Card9 pathway in autoimmune uveitis
BR Brown, EJ Lee, PE Snow, EE Vance, Y Iwakura, N Ohno, N Miura, X Lin, GD Brown, CA Wells, JR Smith, RR Caspi, HL Rosenzweig
Clinical & Experimental Immunology 2017
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation
ML Ratay, E Bellotti, R Gottardi, SR Little
Advanced Healthcare Materials 2017
Ocular antigen does not cause disease unless presented in the context of inflammation
V Voigt, ME Wikstrom, JM Kezic, IS Schuster, P Fleming, K Makinen, SR Daley, CE Andoniou, MA Degli-Esposti, JV Forrester
Scientific Reports 2017
Gut microbiota linked to autoimmune uveitis
R Horai
2017
Checkpoint inhibitor-induced uveitis: a case series.
Conrady CD, Larochelle M, Pecen P, Palestine A, Shakoor A, Singh A
2017
Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.
Tikhonovich MV, Erdiakov AK, Gavrilova SA
International Ophthalmology 2017

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Referenced in 4 patents
Referenced in 1 Wikipedia pages
Pinned by 1 on Pinterest
239 readers on Mendeley
See more details